Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.02+0.64 (+1.63%)
At close: 04:00PM EST
39.22 -0.80 (-2.00%)
After hours: 04:07PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 325.85%
S&P500 52-Week Change 3-9.85%
52 Week High 348.82
52 Week Low 328.25
50-Day Moving Average 339.48
200-Day Moving Average 340.60

Share Statistics

Avg Vol (3 month) 31.09M
Avg Vol (10 day) 31.06M
Shares Outstanding 5142.05M
Implied Shares Outstanding 6N/A
Float 8140.97M
% Held by Insiders 10.56%
% Held by Institutions 190.19%
Shares Short (Jan 12, 2023) 48.14M
Short Ratio (Jan 12, 2023) 46.77
Short % of Float (Jan 12, 2023) 46.78%
Short % of Shares Outstanding (Jan 12, 2023) 45.73%
Shares Short (prior month Dec 14, 2022) 47.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.84%
Operating Margin (ttm)2.36%

Management Effectiveness

Return on Assets (ttm)0.53%
Return on Equity (ttm)1.30%

Income Statement

Revenue (ttm)875.48M
Revenue Per Share (ttm)6.18
Quarterly Revenue Growth (yoy)20.00%
Gross Profit (ttm)167.37M
EBITDA 38.18M
Net Income Avi to Common (ttm)7.32M
Diluted EPS (ttm)0.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.99B
Total Cash Per Share (mrq)14
Total Debt (mrq)1.25B
Total Debt/Equity (mrq)211.06
Current Ratio (mrq)7.59
Book Value Per Share (mrq)4.18

Cash Flow Statement

Operating Cash Flow (ttm)129.51M
Levered Free Cash Flow (ttm)169.6M